Yao Zhengbin
ArriVent BioPharma, Inc. Common Stock · President and CEO
Yao Zhengbin is listed in filings as President and CEO at ArriVent BioPharma, Inc. Common Stock. This profile follows SEC Form 4 activity through Feb 4, 2026, including 2 public disclosures. Recent filings connect the profile to ArriVent BioPharma, Inc. Common Stock (AVBP) and Alumis Inc. Common Stock (ALMS). The current snapshot covers public activity from Aug 1, 2025 to Feb 4, 2026. Reported amounts are shown as $12.5M to $204.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||